Malignant Solid Neoplasm Clinical Trial
Official title:
Palliative, Rehabilitation, and Integrated Medicine Handbook for Self Care at Work Survey
Verified date | March 2023 |
Source | M.D. Anderson Cancer Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
This study investigates the usefulness of the Self Care at Work Handbook in order to generate an improved version. Information from this study may help researchers identify potential factors associated with perception and usefulness of the Self Care at Work Handbook.
Status | Withdrawn |
Enrollment | 0 |
Est. completion date | March 30, 2023 |
Est. primary completion date | March 30, 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | N/A and older |
Eligibility | Inclusion Criteria: - Clinicians in the Department of Palliative, Rehabilitation, and Integrative Medicine. This includes physicians, advanced practice providers (APPs), and other clinical staff in the Supportive Care Center and Acute Palliative Care Unit Exclusion Criteria: No |
Country | Name | City | State |
---|---|---|---|
United States | M D Anderson Cancer Center | Houston | Texas |
Lead Sponsor | Collaborator |
---|---|
M.D. Anderson Cancer Center |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Global perception of usefulness | Will be assessed by survey question E, which has five options: very useful, useful, neither useful nor useless, useless and very useless. The main interest is the proportion of responders who select very useful and useful. | through study completion, an average of 1 year | |
Primary | Frequency of consultation | Will be assessed by survey question D, which has five options: never, once a month or less, a few times a month, a few times a week and daily. The main interest is the proportion of responders who select daily and a few times a week. | through study completion, an average of 1 year | |
Primary | Perceived usefulness of individual items | Will be assessed by survey question F 1-9. Frequency and proportion will be used to summarize each item. For responders who select neither useful nor useless, useless and very useless, additional questions about whether one item should be retained, discarded or modified will be summarized using frequency and proportion. Comments or suggestions will be collected for qualitative analysis. | through study completion, an average of 1 year | |
Primary | Adherence to individual items | Will be assessed by survey question G 1-9. Frequency and proportion will be used to summarize each item. For responders who select neither useful nor useless, useless and very useless, additional questions about whether one item should be retained, discarded or modified will be summarized using frequency and proportion. Comments or suggestions will be collected for qualitative analysis. | through study completion, an average of 1 year | |
Primary | Personal ideas about the handbook | Will be collected by survey question I and question J. Comments and suggestions will be collected and used to aggregate opinions toward handbook improvement. | through study completion, an average of 1 year | |
Primary | Responders' self-reported professional satisfaction | Will be assessed by survey question K, L1, and L3. Association between the perceived usefulness and professional satisfaction will be evaluated by Chi-squared test or Fisher's exact test whichever appropriate. Association between the adherence and professional satisfaction will be evaluated by Chi-squared test or Fisher's exact test whichever appropriate. | through study completion, an average of 1 year | |
Primary | Responders' profession | Will be summarized by survey question A, and responders' demographics will be summarized by survey question B and C. Responders' work satisfaction after coronavirus disease 2019 (COVID-19) will be examined by survey question L2 and L4. Association between the perceived usefulness and responders' profession/demographics/work satisfaction after COVID-19 will be evaluated by Chi-squared test or Fisher's exact test whichever appropriate. Association between the adherence and responders' profession/demographics/work satisfaction after COVID-19 will be evaluated by Chi-squared test or Fisher's exact test whichever appropriate. | through study completion, an average of 1 year | |
Primary | Responders' global perceptions of usefulness and adherence to the handbook during COVID-19 | Will be assessed by survey question M, N and O, and frequency and proportion will be used to summarize the results. | through study completion, an average of 1 year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06030427 -
Virtual Mindfulness and Weight Management to Mitigate Risk of Relapse and Improve Wellbeing in Cancer Survivors
|
N/A | |
Completed |
NCT04337203 -
Shared Healthcare Actions and Reflections Electronic Systems in Survivorship
|
N/A | |
Recruiting |
NCT05660421 -
Itacitinib for the Treatment Steroid Refractory Immune Related Adverse Events Arising From Immune Checkpoint Inhibitors
|
Phase 2 | |
Suspended |
NCT04060849 -
Nozin in Preventing Respiratory Viral Infections in Patients Undergoing Stem Cell Transplant, PREV-NOSE STUDY
|
Phase 1 | |
Recruiting |
NCT06192875 -
A Novel Molecular Approach to Blood DNA Screening for Cancer: Specificity Assessment (The NOMAD Study)
|
||
Completed |
NCT04122118 -
Pharmacist-led Transitions of Care in the Outpatient Oncology Infusion Center for Patients With Solid Tumor
|
N/A | |
Active, not recruiting |
NCT04940299 -
Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma
|
Phase 2 | |
Active, not recruiting |
NCT03168737 -
18F-Fluoroazomycin Arabinoside PET-CT in Diagnosing Solid Tumors in Patients
|
Phase 1 | |
Active, not recruiting |
NCT06062901 -
An Educational Intervention on Provider Knowledge for the Support of Cancer Survivors
|
N/A | |
Active, not recruiting |
NCT02444741 -
Pembrolizumab and Stereotactic Body Radiation Therapy or Non-Stereotactic Wide-Field Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer
|
Phase 1/Phase 2 | |
Terminated |
NCT04081298 -
eHealth Diet and Physical Activity Program for the Improvement of Health in Rural Latino Cancer Survivors
|
N/A | |
Active, not recruiting |
NCT04555837 -
Alisertib and Pembrolizumab for the Treatment of Patients With Rb-deficient Head and Neck Squamous Cell Cancer
|
Phase 1/Phase 2 | |
Completed |
NCT04983901 -
PHASE II SINGLE-CENTER, RANDOMIZED, OPEN-LABEL, PROSPECTIVE, STUDY TO DETERMINE THE IMPACT OF SERIAL PROCALCITONIN
|
Phase 2 | |
Active, not recruiting |
NCT04602026 -
The RIOT Trial: Re-Defining Frailty and Improving Outcomes With Prehabilitation for Pancreatic, Liver, or Gastric Cancer
|
N/A | |
Recruiting |
NCT04871542 -
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
|
||
Active, not recruiting |
NCT04592250 -
Financial Toxicity in Cancer Patients
|
||
Recruiting |
NCT05112614 -
Role of Gut Microbiome in Cancer Therapy
|
||
Active, not recruiting |
NCT04296305 -
Effect of Opioid Infusion Rate on Abuse Liability Potential of Intravenous Hydromorphone for Cancer Pain
|
Phase 4 | |
Recruiting |
NCT05873608 -
Communication Issues in Patient and Provider Discussions of Immunotherapy
|
N/A | |
Recruiting |
NCT02464696 -
Non-invasive Ventilation in Reducing the Need for Intubation in Patients With Cancer and Respiratory Failure
|
N/A |